Skip to main content
Premium Trial:

Request an Annual Quote

NCI Licenses Agilent's Bioinformatics Platforms

NEW YORK (GenomeWeb News) — The National Cancer Institute has purchased a full site license to Agilent Technologies’ bioinformatics products, Agilent announced today.
 
The NCI will use Agilent's GeneSpring, CGH Analytics, Agilent Chip Analytics, and GeneSpring GT platforms for research and analysis.
 
Financial details were not disclosed.

Filed under

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.